Outcome of Multiple Myeloma Patients With Hepatitis Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study

CONCLUSION: Considering the low incidence of HBVr in patients who had received antiviral prophylaxis, HBsAg-positivity should not impede patients from receiving optimal antimyeloma treatment or participating in clinical trials.PMID:37973459 | DOI:10.1016/j.clml.2023.10.004

Source: Clinical Lymphoma and Myeloma - November 16, 2023 Category: Cancer & Oncology Authors: Jun Ho Yi Jung Lim Lee Yoo Jin Lee Hye Jin Kang Young Hoon Park Young Jin Yuh Sung-Nam Lim Hyo Jung Kim Sung-Hoon Jung Je-Jung Lee Hee Jeong Cho Joon Ho Moon Ho-Young Yhim Kihyun Kim Source Type: research